Zhen He Selected Research

Inflammasomes

2/2024

A novel complement C3 inhibitor CP40-KK protects against experimental pulmonary arterial hypertension via an inflammasome NLRP3 associated pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhen He Research Topics

Disease

25	Neoplasms (Cancer) 04/2024 - 11/2014
13	Inflammation (Inflammations) 10/2023 - 07/2014
11	Infections 01/2024 - 01/2012
8	Colitis 01/2024 - 11/2014
8	Ischemia 01/2020 - 01/2002
7	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 01/2017
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 10/2019
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2024 - 12/2016
5	Adenocarcinoma of Lung 06/2022 - 02/2015
5	Non-alcoholic Fatty Liver Disease 10/2021 - 12/2016
4	Lung Neoplasms (Lung Cancer) 04/2024 - 05/2015
3	Disease Progression 04/2024 - 01/2021
3	Obesity 03/2024 - 10/2021
3	Hypoxia (Hypoxemia) 01/2024 - 05/2015
3	Chronic Hepatitis B 01/2024 - 01/2022
3	Carcinogenesis 01/2023 - 01/2015
3	Hypertension (High Blood Pressure) 01/2023 - 01/2022
3	COVID-19 06/2021 - 01/2020
3	Neoplasm Metastasis (Metastasis) 02/2021 - 01/2015
3	Sudden Infant Death (SID) 01/2021 - 01/2020
3	Type 2 Diabetes Mellitus (MODY) 01/2018 - 01/2016
2	Male Infertility (Male Sterility) 05/2024 - 12/2023
2	Reperfusion Injury 03/2024 - 01/2002
2	Pulmonary Arterial Hypertension 02/2024 - 01/2023
2	Crohn Disease (Crohn's Disease) 01/2024 - 01/2015
2	Colitis-Associated Neoplasms 02/2023 - 01/2015
2	Ureteral Obstruction 01/2023 - 12/2022
2	Chronic Renal Insufficiency 01/2023 - 12/2022
2	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 12/2017
2	Necrosis 06/2020 - 07/2013
2	Metabolic Diseases (Metabolic Disease) 05/2020 - 04/2019
2	Stroke (Strokes) 01/2020 - 06/2012
2	Breast Neoplasms (Breast Cancer) 01/2019 - 02/2015
2	Mucoepidermoid Carcinoma 01/2019 - 05/2017
2	Brain Ischemia (Cerebral Ischemia) 09/2005 - 01/2002
1	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 05/2024
1	Hypothyroidism 04/2024
1	Iron Overload 03/2024

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 05/2024 - 11/2014
6	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2019
5	PlatinumIBA 04/2024 - 02/2015
5	RNA (Ribonucleic Acid)IBA 03/2024 - 01/2019
5	Messenger RNA (mRNA)IBA 02/2024 - 07/2019
5	MicroRNAs (MicroRNA)IBA 01/2024 - 12/2016
5	Dextran SulfateIBA 01/2024 - 01/2015
4	anlotinibIBA 04/2024 - 10/2019
4	CytokinesIBA 03/2024 - 01/2015
4	Peptides (Polypeptides)IBA 02/2024 - 12/2005
4	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2022
3	Interleukin-10 (Interleukin 10)IBA 01/2024 - 01/2018
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 01/2018
3	Interleukin-6 (Interleukin 6)IBA 01/2024 - 07/2014
3	ChemokinesIBA 01/2024 - 07/2014
3	Antiviral Agents (Antivirals)IBA 01/2024 - 01/2021
3	EnzymesIBA 03/2023 - 05/2021
3	ErbB Receptors (EGF Receptor)IBA 01/2023 - 04/2022
3	Codon (Codons)IBA 01/2021 - 01/2020
3	Caspase 3 (Caspase-3)IBA 08/2006 - 01/2002
2	LeptinIBA 03/2024 - 05/2015
2	Matrix Metalloproteinases (MMPs)IBA 01/2024 - 01/2021
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2024 - 02/2015
2	Palmitic Acid (Hexadecanoic Acid)IBA 04/2023 - 03/2023
2	CateninsIBA 04/2023 - 03/2023
2	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 02/2023 - 01/2018
2	Bile Acids and Salts (Bile Acids)IBA 02/2023 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 11/2018
2	Triglycerides (Triacylglycerol)IBA 01/2023 - 12/2017
2	Hemoglobins (Hemoglobin)IBA 01/2023 - 01/2023
2	AzoxymethaneIBA 01/2023 - 01/2015
2	Carboplatin (JM8)FDA LinkGeneric 08/2022 - 02/2015
2	Epidermal Growth Factor (EGF)IBA 10/2021 - 01/2021
2	LigandsIBA 05/2021 - 10/2016
2	Interleukin-4 (Interleukin 4)IBA 05/2021 - 01/2021
2	Etoposide (VP 16)FDA LinkGeneric 02/2021 - 01/2021
2	Mitogen-Activated Protein KinasesIBA 01/2021 - 05/2014
2	CrizotinibIBA 01/2021 - 01/2019
2	LipidsIBA 04/2019 - 12/2016
2	Adenosine Monophosphate (AMP)IBA 01/2019 - 01/2019
2	Ribosomal DNA (rDNA)IBA 01/2019 - 01/2018
2	Gefitinib (Iressa)FDA Link 01/2019 - 05/2017
2	Phenobarbital (Luminal)FDA Link 01/2018 - 02/2015
2	Cisplatin (Platino)FDA LinkGeneric 12/2016 - 02/2015
2	Uric Acid (Urate)IBA 07/2016 - 01/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2015 - 01/2015
2	salicylhydroxamic acid (SHAM)IBA 12/2005 - 09/2005
2	NestinIBA 09/2005 - 12/2004
1	Neurotransmitter Agents (Neurotransmitter)IBA 05/2024
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 04/2024
1	sintilimabIBA 04/2024
1	MB Form Creatine KinaseIBA 04/2024
1	Deferoxamine (Desferal)FDA LinkGeneric 03/2024
1	IronIBA 03/2024
1	Insulin (Novolin)FDA Link 03/2024
1	Transferrin Receptors (Transferrin Receptor)IBA 03/2024
1	InflammasomesIBA 02/2024

Therapy/Procedure

19	Therapeutics 04/2024 - 05/2015
8	Drug Therapy (Chemotherapy) 04/2024 - 02/2015
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 08/2023 - 12/2022
1	Liver Transplantation 03/2024
1	Perioperative Period 03/2024